Cusatuzumab is a human αCD70 моноклональный антитело. Cusatuzumab shows cytotoxicity activity with enhanced антитело-dependent клеточный. Cusatuzumab reduces leukemia stem cells (LSCs) and triggers gene signatures related to myeloid differentiation and apoptosis. Cusatuzumab has the potential for the research of Acute myeloid leukemia (AML).
Cusatuzumab is a human αCD70 monoclonal antibody. Cusatuzumab shows cytotoxicity activity with enhanced antibody-dependent cellular. Cusatuzumab reduces leukemia stem cells (LSCs) and triggers gene signatures related to myeloid differentiation and apoptosis. Cusatuzumab has the potential for the research of Acute myeloid leukemia (AML).
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.